Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (335)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
29
2025
187
13.000
 Why?
Anticonvulsants
20
2025
134
8.960
 Why?
Seizures
24
2025
209
6.200
 Why?
Tuberous Sclerosis
8
2025
39
4.330
 Why?
Spasms, Infantile
11
2025
30
4.210
 Why?
Cannabidiol
8
2025
43
4.000
 Why?
Status Epilepticus
6
2021
37
3.310
 Why?
Epilepsies, Myoclonic
5
2024
14
3.080
 Why?
Mutation
16
2023
1344
3.020
 Why?
Deep Brain Stimulation
4
2025
43
2.820
 Why?
Humans
117
2025
52593
2.650
 Why?
Electroencephalography
18
2024
313
2.480
 Why?
Intellectual Disability
5
2023
127
2.180
 Why?
Child
42
2025
7229
2.180
 Why?
Brain
10
2024
1325
2.110
 Why?
Hemiplegia
3
2021
11
2.000
 Why?
Developmental Disabilities
5
2019
121
1.680
 Why?
Epilepsy, Absence
3
2019
11
1.630
 Why?
Magnetic Resonance Imaging
16
2025
1545
1.590
 Why?
Infant
24
2025
3720
1.560
 Why?
Genetic Therapy
2
2025
122
1.480
 Why?
Algorithms
2
2025
668
1.390
 Why?
Tumor Suppressor Proteins
3
2023
128
1.390
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.390
 Why?
Nervous System Malformations
3
2020
16
1.380
 Why?
Folate Receptor 1
2
2022
27
1.350
 Why?
Child, Preschool
22
2025
4062
1.310
 Why?
Epilepsies, Partial
2
2022
14
1.270
 Why?
Infant, Newborn, Diseases
2
2020
57
1.270
 Why?
Ketamine
2
2020
59
1.260
 Why?
Vagus Nerve Stimulation
2
2025
14
1.150
 Why?
Neurocutaneous Syndromes
2
2019
6
1.140
 Why?
Cadherins
2
2019
63
1.120
 Why?
Cerebral Arteries
2
2019
30
1.050
 Why?
Epilepsy, Generalized
2
2023
9
1.030
 Why?
Vigabatrin
3
2024
3
1.020
 Why?
Sirolimus
2
2017
72
1.000
 Why?
Angiofibroma
2
2015
5
0.980
 Why?
Facial Neoplasms
2
2015
22
0.960
 Why?
Male
37
2025
26863
0.950
 Why?
Nerve Tissue Proteins
2
2018
192
0.950
 Why?
Treatment Outcome
13
2025
5486
0.940
 Why?
Valproic Acid
2
2022
35
0.940
 Why?
Neurosurgical Procedures
2
2025
135
0.930
 Why?
Female
33
2025
28262
0.930
 Why?
Stroke
3
2019
515
0.900
 Why?
Fenfluramine
2
2024
8
0.900
 Why?
Randomized Controlled Trials as Topic
2
2024
600
0.880
 Why?
Dioxolanes
2
2024
15
0.880
 Why?
Thalamus
1
2024
35
0.880
 Why?
Pregnanolone
2
2023
6
0.860
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.810
 Why?
Quality Improvement
2
2022
224
0.770
 Why?
Aphasia
1
2022
33
0.770
 Why?
Nervous System Diseases
2
2021
94
0.750
 Why?
Chromosome Deletion
3
2019
141
0.740
 Why?
Abnormalities, Multiple
3
2023
168
0.740
 Why?
Emergencies
1
2021
81
0.710
 Why?
Pharmaceutical Preparations
1
2021
75
0.710
 Why?
Angelman Syndrome
1
2020
1
0.690
 Why?
Transition to Adult Care
1
2020
18
0.680
 Why?
Bone Diseases, Developmental
2
2023
17
0.670
 Why?
Tooth Abnormalities
2
2023
13
0.670
 Why?
Immunoglobulins, Intravenous
1
2021
63
0.670
 Why?
Adolescent
15
2025
6737
0.660
 Why?
Oligonucleotides, Antisense
1
2020
29
0.660
 Why?
Phenobarbital
1
2020
17
0.660
 Why?
Flunarizine
1
2019
1
0.650
 Why?
Behavioral Symptoms
1
2019
4
0.650
 Why?
Immunologic Factors
1
2021
117
0.650
 Why?
Excitatory Amino Acid Antagonists
1
2020
46
0.650
 Why?
Ocular Physiological Phenomena
1
2019
3
0.640
 Why?
Tetrasomy
1
2019
2
0.640
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.630
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.630
 Why?
Sneddon Syndrome
1
2019
3
0.630
 Why?
Livedo Reticularis
1
2019
5
0.630
 Why?
Oral Ulcer
1
2019
3
0.630
 Why?
Calcium Channel Blockers
1
2019
60
0.630
 Why?
Behcet Syndrome
1
2019
7
0.620
 Why?
Transposases
1
2019
10
0.620
 Why?
Andersen Syndrome
1
2019
1
0.620
 Why?
Spinal Cord Diseases
1
2019
39
0.620
 Why?
Hydrocephalus
1
2019
43
0.620
 Why?
Receptors, GABA-B
1
2019
12
0.610
 Why?
Vitiligo
1
2019
8
0.610
 Why?
Leukoencephalopathies
1
2019
14
0.610
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.610
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.610
 Why?
Migraine Disorders
2
2020
47
0.600
 Why?
Edema
1
2019
66
0.600
 Why?
Cerebral Infarction
1
2018
31
0.600
 Why?
Electron Transport Complex IV
1
2018
24
0.600
 Why?
Muscle Weakness
1
2019
45
0.600
 Why?
Nephrotic Syndrome
2
2017
34
0.600
 Why?
Cannabinoid Receptor Agonists
1
2019
51
0.600
 Why?
Physicians
1
2022
241
0.590
 Why?
Optic Atrophy
1
2018
16
0.590
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.590
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.590
 Why?
Photic Stimulation
1
2018
56
0.590
 Why?
Shab Potassium Channels
1
2018
2
0.590
 Why?
Alopecia
1
2019
38
0.590
 Why?
Brain Edema
1
2018
36
0.580
 Why?
Parents
1
2021
332
0.580
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.570
 Why?
Myoclonus
1
2018
9
0.570
 Why?
Artifacts
1
2018
55
0.570
 Why?
Thrombocytopenia
1
2019
92
0.570
 Why?
Autoimmune Diseases
1
2019
87
0.570
 Why?
Biomedical Research
1
2021
258
0.570
 Why?
Mitochondrial Diseases
1
2018
45
0.560
 Why?
Neurodegenerative Diseases
1
2018
81
0.550
 Why?
Practice Guidelines as Topic
1
2020
496
0.550
 Why?
Hearing Loss, Sensorineural
1
2018
79
0.540
 Why?
Osteochondrodysplasias
1
2017
14
0.540
 Why?
Immunologic Deficiency Syndromes
1
2017
18
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
510
0.540
 Why?
Models, Biological
1
2020
741
0.530
 Why?
Arteriosclerosis
1
2017
50
0.530
 Why?
Carotid Artery Diseases
1
2017
31
0.530
 Why?
Infant, Newborn
6
2024
2891
0.530
 Why?
Phenotype
2
2021
800
0.530
 Why?
Drug Discovery
1
2017
93
0.520
 Why?
Child Development
1
2018
201
0.510
 Why?
Prenatal Exposure Delayed Effects
1
2018
197
0.510
 Why?
Cafe-au-Lait Spots
1
2016
2
0.510
 Why?
Skin
1
2019
418
0.500
 Why?
Williams Syndrome
1
2016
25
0.500
 Why?
Erythema Infectiosum
1
2015
3
0.500
 Why?
Corpus Callosum
2
2023
26
0.500
 Why?
Migraine with Aura
1
2015
5
0.500
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.500
 Why?
Sinus Pericranii
1
2015
1
0.490
 Why?
Pulmonary Embolism
1
2017
85
0.490
 Why?
Syndrome
6
2024
253
0.490
 Why?
Parvovirus B19, Human
1
2015
17
0.490
 Why?
Toes
1
2015
15
0.490
 Why?
Electrodiagnosis
1
2015
13
0.490
 Why?
SOS1 Protein
1
2015
2
0.490
 Why?
Crying
1
2015
4
0.490
 Why?
Moyamoya Disease
1
2015
7
0.490
 Why?
Hyperventilation
1
2015
8
0.490
 Why?
Iatrogenic Disease
1
2015
26
0.480
 Why?
Tuberculoma
1
2015
1
0.480
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.480
 Why?
Noonan Syndrome
1
2015
12
0.480
 Why?
Neurologic Examination
1
2015
73
0.480
 Why?
Encephalitis
1
2016
39
0.480
 Why?
Ocular Motility Disorders
1
2015
17
0.470
 Why?
Communication
3
2022
257
0.470
 Why?
Mutism
1
2015
3
0.470
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.470
 Why?
Repressor Proteins
2
2023
154
0.470
 Why?
TOR Serine-Threonine Kinases
1
2015
82
0.470
 Why?
Diagnosis, Differential
7
2020
1048
0.460
 Why?
Trisomy
1
2014
35
0.460
 Why?
Influenza, Human
1
2015
85
0.450
 Why?
Neurology
1
2015
35
0.450
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.450
 Why?
Energy Drinks
1
2014
6
0.450
 Why?
Vasoconstriction
1
2014
56
0.440
 Why?
Benzodiazepines
1
2014
72
0.440
 Why?
Osteomyelitis
1
2015
125
0.430
 Why?
Membrane Proteins
1
2016
337
0.430
 Why?
Sleep
1
2014
186
0.410
 Why?
Enzyme Inhibitors
1
2015
372
0.410
 Why?
Quality of Life
4
2025
882
0.390
 Why?
Magnetic Resonance Angiography
3
2019
67
0.390
 Why?
Immunosuppressive Agents
3
2019
250
0.380
 Why?
Consensus
2
2025
190
0.380
 Why?
Pediatrics
1
2015
295
0.370
 Why?
Retrospective Studies
8
2025
6671
0.360
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
79
0.350
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
133
0.330
 Why?
Clinical Trials as Topic
2
2024
472
0.330
 Why?
Caregivers
2
2021
238
0.310
 Why?
Recurrence
3
2019
683
0.300
 Why?
Echinocandins
1
2008
64
0.290
 Why?
Mycoses
1
2008
152
0.280
 Why?
Gastroesophageal Reflux
2
2019
48
0.270
 Why?
Antifungal Agents
1
2008
347
0.250
 Why?
Administration, Topical
2
2015
60
0.240
 Why?
Adult
6
2025
14170
0.240
 Why?
Seizures, Febrile
1
2024
2
0.230
 Why?
Meta-Analysis as Topic
1
2024
40
0.230
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.220
 Why?
Psychosurgery
1
2023
5
0.220
 Why?
Databases, Factual
2
2024
715
0.220
 Why?
Laser Therapy
1
2023
76
0.200
 Why?
Speech Disorders
1
2022
16
0.200
 Why?
Ethosuximide
1
2022
5
0.200
 Why?
Clonazepam
1
2022
6
0.200
 Why?
Electrodes, Implanted
1
2022
32
0.200
 Why?
Cluster Analysis
1
2023
233
0.190
 Why?
Stereotaxic Techniques
1
2022
40
0.190
 Why?
Death, Sudden
1
2022
9
0.190
 Why?
GTPase-Activating Proteins
1
2022
25
0.190
 Why?
Concept Formation
1
2021
12
0.190
 Why?
Palliative Care
1
2024
216
0.190
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.190
 Why?
Freedom
1
2021
3
0.190
 Why?
Folic Acid
1
2022
136
0.180
 Why?
Diazepam
1
2021
18
0.180
 Why?
Drug Interactions
1
2022
205
0.180
 Why?
Fibroma
1
2021
40
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
30
0.180
 Why?
Personal Satisfaction
1
2021
75
0.170
 Why?
Soft Tissue Neoplasms
1
2021
55
0.170
 Why?
Dihydroergotamine
1
2020
5
0.170
 Why?
Risk Factors
2
2020
3952
0.170
 Why?
Brain Diseases
1
2021
77
0.170
 Why?
Perception
1
2021
120
0.170
 Why?
Transcription Factors
2
2023
566
0.170
 Why?
Mental Disorders
1
2025
428
0.170
 Why?
Facies
2
2023
36
0.170
 Why?
Diet Therapy
1
2020
8
0.170
 Why?
Genetic Diseases, Inborn
1
2020
24
0.170
 Why?
Clinical Protocols
1
2020
108
0.160
 Why?
Treatment Failure
1
2020
122
0.160
 Why?
Anesthetics
1
2020
36
0.160
 Why?
Leukomalacia, Periventricular
1
2019
12
0.160
 Why?
Learning
1
2021
161
0.160
 Why?
Muscle Hypotonia
1
2019
23
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
30
0.160
 Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.160
 Why?
HLA-B51 Antigen
1
2019
2
0.160
 Why?
Qualitative Research
1
2021
362
0.160
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
29
0.160
 Why?
Patient-Centered Care
1
2021
140
0.160
 Why?
Ubiquitin-Protein Ligases
1
2020
137
0.160
 Why?
Heart Septal Defects, Atrial
1
2019
45
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
 Why?
Ventricular Premature Complexes
1
2019
6
0.150
 Why?
Disease Management
1
2020
188
0.150
 Why?
Microcephaly
1
2019
41
0.150
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Referral and Consultation
1
2021
292
0.150
 Why?
Syncope
1
2019
31
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
17
0.150
 Why?
Facial Paralysis
1
2018
25
0.150
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.150
 Why?
Health Personnel
1
2021
252
0.150
 Why?
Deglutition Disorders
1
2019
79
0.150
 Why?
Acute Disease
1
2019
387
0.150
 Why?
Fatal Outcome
1
2019
196
0.150
 Why?
Video Recording
1
2018
79
0.140
 Why?
Frameshift Mutation
1
2018
18
0.140
 Why?
Fibrinolytic Agents
1
2019
131
0.140
 Why?
Combined Modality Therapy
1
2020
639
0.140
 Why?
Anti-Inflammatory Agents
1
2019
166
0.140
 Why?
Fear
1
2018
82
0.140
 Why?
India
1
2017
64
0.140
 Why?
Cerebellum
1
2018
126
0.140
 Why?
History, 21st Century
1
2017
59
0.140
 Why?
History, 20th Century
1
2017
96
0.140
 Why?
Platelet Aggregation Inhibitors
1
2019
213
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.140
 Why?
Methotrexate
1
2017
77
0.130
 Why?
Pandemics
1
2021
587
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
92
0.130
 Why?
Animals
3
2022
13507
0.130
 Why?
Anti-Infective Agents
1
2017
106
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
25
0.130
 Why?
Hormones
1
2016
59
0.120
 Why?
Influenza B virus
1
2015
6
0.120
 Why?
Delayed Diagnosis
1
2016
30
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
 Why?
Arkansas
1
2021
2029
0.120
 Why?
North America
1
2015
77
0.120
 Why?
Cerebral Angiography
1
2015
90
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
79
0.120
 Why?
Complementary Therapies
1
2015
23
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.120
 Why?
Brain Waves
1
2014
19
0.110
 Why?
Drug Resistance
1
2015
68
0.110
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
460
0.110
 Why?
Headache
1
2014
76
0.110
 Why?
Mutation, Missense
1
2014
108
0.110
 Why?
Glutamine
1
2015
176
0.110
 Why?
Vomiting
1
2014
73
0.110
 Why?
Arginine
1
2015
182
0.100
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.100
 Why?
Analgesics
1
2014
106
0.100
 Why?
Diagnostic Errors
1
2013
69
0.100
 Why?
Evidence-Based Medicine
1
2013
269
0.090
 Why?
Inflammation
1
2016
644
0.090
 Why?
Pregnancy
1
2018
2679
0.090
 Why?
Signal Transduction
1
2017
1714
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Antineoplastic Agents
1
2017
1221
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
44
0.070
 Why?
Lipopeptides
1
2008
62
0.070
 Why?
Amyloidosis
1
2009
85
0.070
 Why?
Tuberculosis
1
2009
152
0.070
 Why?
Candidiasis
1
2008
113
0.070
 Why?
Aspergillosis
1
2008
122
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
86
0.070
 Why?
Kidney Diseases
1
2009
231
0.060
 Why?
Prospective Studies
2
2023
2457
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
48
0.060
 Why?
Observer Variation
1
2024
133
0.050
 Why?
Spasm
1
2024
9
0.050
 Why?
Feedback
1
2024
52
0.050
 Why?
Kaplan-Meier Estimate
1
2025
485
0.050
 Why?
Probability
1
2023
173
0.050
 Why?
Young Adult
2
2025
4337
0.050
 Why?
Neuroimaging
1
2023
94
0.050
 Why?
Potassium Channels
1
2021
32
0.050
 Why?
Reproducibility of Results
1
2024
1217
0.040
 Why?
Registries
1
2024
629
0.040
 Why?
Administration, Intravenous
1
2020
74
0.040
 Why?
Sleep Stages
1
2020
40
0.040
 Why?
Age of Onset
1
2020
110
0.040
 Why?
Cognition
1
2022
330
0.040
 Why?
Follow-Up Studies
1
2025
2291
0.040
 Why?
Immunohistochemistry
1
2021
984
0.040
 Why?
Aged
1
2025
10191
0.020
 Why?
Software
1
2013
280
0.020
 Why?
Internet
1
2013
262
0.020
 Why?
Middle Aged
1
2025
13096
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
107
0.020
 Why?
Colonoscopy
1
2009
108
0.020
 Why?
Prognosis
1
2009
2118
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (335) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department